PsyBio Therapeutics Corp. (PSYBF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Jul 21, 2026
PsyBio Therapeutics Market Cap
PsyBio Therapeutics has a market cap or net worth of $133 as of October 9, 2026. It is the 52,813th most valuable company in the world and the 8,838th biggest in the United States.
Market Cap
133.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,838 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 23, 2021, PsyBio Therapeutics's market cap has decreased from 38.24M to 133.00, a decrease of -100.00%. That is a compound annual growth rate of -90.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 133.00 | - |
| Dec 22, 2025 | 133.00 | - |
| Dec 5, 2024 | 133.00 | -99.98% |
| Dec 29, 2023 | 583.50K | -80.15% |
| Dec 30, 2022 | 2.94M | -83.74% |
| Dec 31, 2021 | 18.07M | -52.73% |
| Apr 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| Marizyme | 132.00 |
| HEALTHeUNIVERSE | 118.00 |